ferrous sulfide has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Li, G; Ning, S; Qiao, K; Xu, S; Zheng, Y | 1 |
| Bai, F; Darash Yahana, M; Ioannidis, K; Jennings, PA; Karmi, O; Marjault, HB; Mittler, R; Morcos, F; Nahmias, Y; Nechushtai, R; Onuchic, JN; Roy, S; Sohn, YS | 1 |
2 other study(ies) available for ferrous sulfide and Breast Neoplasms
| Article | Year |
|---|---|
Laser-triggered combination therapy by iron sulfide-doxorubicin@functionalized nanozymes for breast cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Therapy; Female; Ferrous Compounds; Lactoferrin; Laser Therapy; Lasers; Mice | 2021 |
A VDAC1-mediated NEET protein chain transfers [2Fe-2S] clusters between the mitochondria and the cytosol and impacts mitochondrial dynamics.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Computer Simulation; Cytosol; Extracellular Matrix; Female; Ferrous Compounds; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hydrogen-Ion Concentration; Mice; Mice, Nude; Mitochondria; Neoplasms, Experimental; Oxygen Consumption; Voltage-Dependent Anion Channel 1 | 2022 |